Interpretation of subclinical thyroid dysfunction
General concept
Subclinical thyroid dysfunction is a relatively common condition in clinical practice and is characterised by abnormal thyroid-stimulating hormone, or TSH, levels with normal concentrations of free thyroid hormones. In most cases, it is identified incidentally during routine blood tests and often raises questions about whether treatment or surveillance alone is required.
Diagnostic confirmation
When an isolated TSH abnormality is identified, the first step is to confirm that it is truly persistent. Several factors can cause transient changes in laboratory values, including intercurrent illness, recent medication changes and normal biological variation. For this reason, laboratory testing should be repeated after several weeks, including TSH and free T4. When subclinical hypothyroidism is suspected, measurement of thyroid peroxidase antibodies, or anti-TPO antibodies, may provide important additional information.
Subclinical hypothyroidism
When TSH is elevated and free T4 remains normal, possible subclinical hypothyroidism should be considered. Once the abnormality has been confirmed, the treatment decision depends mainly on the magnitude of the TSH elevation and the patient’s characteristics. There is relatively strong consensus that persistently elevated values of 10 mU/L or higher usually justify starting levothyroxine treatment because of the greater risk of progression to overt hypothyroidism and the potential associated cardiovascular and metabolic consequences.
When should treatment be considered with TSH below 10 mU/L?
The situation becomes more complex when TSH is elevated but remains below this threshold. In these cases, the decision should be individualised. The presence of symptoms compatible with hypothyroidism, although often non-specific, may favour treatment. Significant dyslipidaemia, infertility, ovulatory dysfunction or a progressive rise in TSH levels over time may also influence the decision.
Pregnancy and fertility
Pregnancy and plans to conceive require particular attention. During this period, even mild thyroid function abnormalities may have relevant implications for fertility, embryo implantation and pregnancy outcomes. Consequently, a more proactive approach is generally favoured in women who are planning pregnancy or who are already pregnant.
Importance of anti-TPO antibodies
Another important factor is the presence of positive anti-TPO antibodies. These antibodies usually suggest an autoimmune cause, most commonly Hashimoto thyroiditis, and are associated with a greater likelihood of progression to overt hypothyroidism. Although their presence alone does not necessarily constitute an indication for treatment, it is a factor that may support treatment when considered together with other clinical findings.
Influence of age
The patient’s age should also be considered. Younger individuals are more likely to benefit from correction of subclinical thyroid dysfunction when other factors favouring treatment are present. By contrast, a more conservative approach is generally adopted in older adults, particularly those over 65 years of age, because the benefits are less clear and the risk of harm from excessive thyroid hormone replacement is greater.
Structural assessment of the thyroid
In addition to laboratory assessment, clinical examination remains important. The presence of goitre, structural thyroid abnormalities or a family history of autoimmune disease may warrant further investigation, including thyroid ultrasound in selected situations.
Subclinical hyperthyroidism
At the opposite end of the spectrum is subclinical hyperthyroidism, defined by a low TSH with normal free T4 and free T3 levels. As with subclinical hypothyroidism, the abnormality should be confirmed by repeat laboratory assessment before establishing a definitive diagnosis.
When should referral be considered?
When the reduction in TSH is mild, the usual strategy is clinical and laboratory surveillance. However, persistently low values below 0.1 mU/L require particular attention. In this situation, the risk of atrial fibrillation, loss of bone mass and cardiovascular complications increases, especially in older individuals. Referral to Endocrinology is therefore generally indicated for investigation of the underlying cause and definition of the most appropriate treatment strategy.
T3-predominant thyrotoxicosis
It is also important to remember that a low TSH does not always correspond to true subclinical hyperthyroidism. Some conditions may progress to a phase of T3-predominant thyrotoxicosis, which is why assessment of free thyroid hormones remains central to the investigation.
Key message
The approach to subclinical thyroid dysfunction requires laboratory confirmation, careful assessment of risk factors and individualisation of the treatment decision. Not all patients require treatment, but certain groups clearly benefit from earlier intervention. The aim is to identify those most likely to experience progression or develop complications while avoiding overtreatment of laboratory abnormalities with limited clinical relevance.
